Gaudium IVF IPO Opens Today: GMP at 15% Premium

[{ "selector": ".fmzmb-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateX(calc(360px - 291px)) scale(0.15)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateX(0px) scale(1)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".pgcdw-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "opacity": 0, "visibility" :"visible"}, {"offset": 1, "opacity": "1", "visibility" :"visible"} ] }]

Issue Details:

₹165 crore IPO opens Feb 20-24. Fresh issue ₹90 crore, OFS ₹75 crore. Price band ₹75-79. Minimum lot 189 shares (₹14,931 investment).

[{ "selector": ".gwlut-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-15px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".oexci-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(calc(600px - 550px))", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }]

Strong GMP Signal:

Grey market premium at ₹12 (15% above upper band). Unlisted shares trading at ₹91. Anchor book raised ₹49.5 crore pre-IPO.

[{ "selector": ".wqapk-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-15px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".zncnr-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(calc(600px - 550px))", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }]

Growth Plans:

Funds to establish 19 new IVF centres nationwide. ₹20 crore for debt repayment. Operates 30+ locations via hub-and-spoke model.

[{ "selector": ".ldsdn-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-15px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".bxpnl-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(calc(600px - 550px))", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }] Click Here

India's First Listed IVF Player:

58% clinical success rate. FY25 profit ₹19.13 crore. Market valued at 22.98x FY26 annualized EPS. Analysts recommend 'Subscribe' rating.

[{ "selector": ".qmdws-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-15px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".aejpg-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(calc(600px - 550px))", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }]

Key Dates & Risks:

Allotment Feb 25, listing Feb 27 on BSE/NSE. High employee attrition (31%) and ₹45 crore contingent liabilities noted in RHP.

[{ "selector": ".ilxiu-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-15px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".zcleu-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(calc(600px - 550px))", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }]

With Our Subscription Plans

[{ "selector": ".igkjg-a", "duration": "500ms", "fill": "forwards", "delay": "0ms", "keyframes": [ {"offset": 0, "opacity": 0, "visibility" :"visible"}, {"offset": 1, "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".lbeod-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "opacity": 0, "visibility" :"visible"}, {"offset": 1, "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".nqbwm-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateX(-299px)", "opacity": "1", "visibility" :"visible" }, {"offset": 1, "transform": "translateX(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".rtjnb-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-33px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }] Open Demat A/C

Gaudium IVF IPO Opens Today: GMP at 15% Premium

Issue Details: ₹165 crore IPO opens Feb 20-24. Fresh issue ₹90 crore, OFS ₹75 crore. Price band ₹75-79. Minimum lot 189 shares (₹14,931 investment).

Strong GMP Signal: Grey market premium at ₹12 (15% above upper band). Unlisted shares trading at ₹91. Anchor book raised ₹49.5 crore pre-IPO.

Growth Plans: Funds to establish 19 new IVF centres nationwide. ₹20 crore for debt repayment. Operates 30+ locations via hub-and-spoke model.

India's First Listed IVF Player: 58% clinical success rate. FY25 profit ₹19.13 crore. Market valued at 22.98x FY26 annualized EPS. Analysts recommend 'Subscribe' rating.

Key Dates & Risks: Allotment Feb 25, listing Feb 27 on BSE/NSE. High employee attrition (31%) and ₹45 crore contingent liabilities noted in RHP.